Wells Fargo Says Buy Micro-Cap Drugmaker Ahead Of Cancer Immunotherapy Meeting

Shares of Infinity Pharmaceuticals are on the rise after Wells Fargo analyst Jim Birchenough upgraded the stock to a buy-equivalent rating.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.